Nanotechnology: Going small for a giant leap in cancer diagnostics and therapeutics

Marco A. Pierotti, Claudio Lombardo, Camillo Rosano

Research output: Contribution to journalArticlepeer-review


More than 30 years ago Richard Feynman pointed out that physicists knew no limits to prevent us from doing engineering at the level of atoms. Until recently, though, while the lack of physical limits was accepted as commonplace, molecular engineering was thought of as impractical, unnecessary, or requiring breakthroughs in knowledge and technique that placed it somewhere in the distant future. Many visionaries intimately familiar with the development of silicon technology still forecast it would take between 20 and 50 years before molecular engineering became a reality. This is well beyond the planning horizon of most companies. But recently, everything has begun to change. After the industrial revolution and the "computer age", are we really facing a new era?

Original languageEnglish
Pages (from-to)191-196
Number of pages6
Issue number2
Publication statusPublished - Mar 2008


  • Drug delivery
  • Nanomedicine
  • Nanoparticles
  • Nanotechnology

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Nanotechnology: Going small for a giant leap in cancer diagnostics and therapeutics'. Together they form a unique fingerprint.

Cite this